ReviewCureus2026
Why Seizures Break Through: Distinguishing Background Susceptibility From Proximal Precipitants in Patients With Epilepsy.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breakthrough seizures are commonly described as unprovoked seizures that recur in patients with epilepsy who remain on antiseizure medication (ASM) after a sustained period of seizure freedom. These events are clinically important because they can disrupt previously stable seizure control and alter counseling, safety considerations, and treatment decisions. The literature often combines two conceptually different explanations: background factors that reflect a greater underlying propensity for recurrence and proximal exposures that may help explain why a seizure occurs at a particular time. This focused narrative review distinguishes these concepts and evaluates the strength of evidence supporting each. Breakthrough-specific studies suggest that greater prior seizure burden, difficulty achieving remission, neurological impairment, treatment history, and epilepsy etiology may reflect greater background susceptibility. In contrast, frequently cited precipitants such as medication nonadherence, sleep deprivation, psychological stress, infection, alcohol exposure, and pregnancy vary considerably in evidentiary strength. Nonadherence has relatively strong mechanistic and objective support, although inadequate medication exposure can complicate whether an event should be classified as a breakthrough seizure. Sleep deprivation and stress are commonly reported and biologically plausible, but their independent causal contributions remain uncertain. Heavy alcohol exposure appears more clinically relevant than modest intake. Pregnancy may alter ASM exposure in a medication-specific manner, but available evidence does not support treating pregnancy as a uniform independent cause of seizure worsening. Precipitants may also cluster, making attribution to a single exposure potentially misleading. Broader electrophysiological evidence further suggests that underlying seizure susceptibility may fluctuate over time. Distinguishing background susceptibility from proximal precipitants provides a practical framework for prognosis, counseling, medication management, and future research while emphasizing the difference between association and demonstrated causation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.